This document discusses amyloidosis, a condition caused by extracellular deposition of fibrillar proteins that can damage tissues. There are two main types - AL amyloidosis associated with plasma cell disorders and AA amyloidosis linked to inflammation. Common sites of deposition include kidneys, liver, spleen, and heart. Amyloid is identified on histology as an extracellular eosinophilic deposit that stains red with Congo red dye under polarized light. The deposits can obstruct organs over time and cause nonspecific symptoms. Biopsy with Congo red staining is important for diagnosis.
by post graduates from Maratha Mandal's NathajiRao Halgekar Institute of Dental Sciences, Belgavi.
A step wise presentation of Amylodosis covering,
INTRODUCTION
DEFINITION
HISTORY
PHYSICAL NATURE
CHEMICAL NATURE
CLASSIFICATION
PATHOGENESIS
STAINING CHARACTERISTICS
DIAGNOSTIC TESTS
MORPHOLOGY
CLINICAL FEATURES
TREATMENT
PROGNOSIS
made as a part of residency programme in dermatology. includes latest classification.includes staining characteristics. good for revision. made from contents from Rooks and Bolognia
by post graduates from Maratha Mandal's NathajiRao Halgekar Institute of Dental Sciences, Belgavi.
A step wise presentation of Amylodosis covering,
INTRODUCTION
DEFINITION
HISTORY
PHYSICAL NATURE
CHEMICAL NATURE
CLASSIFICATION
PATHOGENESIS
STAINING CHARACTERISTICS
DIAGNOSTIC TESTS
MORPHOLOGY
CLINICAL FEATURES
TREATMENT
PROGNOSIS
made as a part of residency programme in dermatology. includes latest classification.includes staining characteristics. good for revision. made from contents from Rooks and Bolognia
amyloidosis(including history,physical and chemical properties, classification, variants, staining characteristics, lab diagnosis,morphological patterns according to organ involved ,), basically for undergraduates and residents in pathology
This is a series of notes on general pathology.. Amyloidosis is a very important topic from exam point of view both for under and post graduates..topic is presented here with enough colour illustrations
amyloidosis(including history,physical and chemical properties, classification, variants, staining characteristics, lab diagnosis,morphological patterns according to organ involved ,), basically for undergraduates and residents in pathology
This is a series of notes on general pathology.. Amyloidosis is a very important topic from exam point of view both for under and post graduates..topic is presented here with enough colour illustrations
MBBS PPT - AMYLOIDOSIS types diagnostic approach and staining characteristic...DrDivitasaxena1
Amyloidosis is caused by extracellular deposition of fibrillar proteins which leads to tissue damage and functional compromise
Abnormal fibrils are produced by aggregation of misfolded proteins
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
2. • Amyloidosis is a condition associated with a number
of inherited and inflammatory disorders in which
extracellular deposits of fibrillar proteins are
responsible for tissue damage and functional
compromise
3.
4. fibrillar deposits bind proteoglycans and glycosaminoglycans
abundant charged sugar groups in these adsorbed proteins gives deposit staining
resemble starch (amylose).
deposits are unrelated to starch.
5. • nonbranching fibrils, 7.5 to 10 nm in diameter, each formed of β-sheet
polypeptide chains that are wound together
misfolded proteins
degraded intracellularly in proteasomes extracellularly by
macrophages
accumulate outside the cells
6. • two general categories:
(1) normal proteins that have an inherent tendency to fold improperly,
associate to form fibrils when they are produced in increased amounts
(2) mutant proteins that are prone to misfolding and subsequent
aggregation
7. • 3 most common amyloid :
AL Amyloid : plasma cells
made up of complete immunoglobulin light chains, the amino-
terminal fragments of light chains, or both.
a/w monoclonal B cell proliferation
Defective degradation
particular light chains are resistant to complete proteolysis
8.
9. • The AA fibril :
SAA AA
(liver)
IL-6 and IL-1 (inflammation)
SAA monocyte-derived enzymes soluble end products
a genetically determined structural abnormality in the SAA molecule itself renders
it resistant to degradation by macrophages
10. • Aβ amyloid - cerebral lesions of Alzheimer disease.
amyloid precursor protein (APP) -------- Aβ
other proteins : Transthyretin (TTR)
normal protein binds and transports thyroxine and retinol
mutations - prone to misfolding and aggregation, and resistant to proteolysis.
Familial amyloid polyneuropathies
heart of aged persons (senile systemic amyloidosis) - structurally normal, but
accumulates at high concentrations.
11. • β2-Microglobulin - component of MHC class I molecules and a normal serum
protein,
• fibril subunit (Aβ2m) in amyloidosis
long-term hemodialysis
retained in the circulation because it is not
efficiently filtered through dialysis
membranes.
12.
13. On clinical grounds, systemic
primary amyloidosis ------ associated with a monoclonal plasma cell proliferation
secondary amyloidosis ------ complication of an underlying chronic inflammatory or
tissue destructive process
14. • Primary - heart, gastrointestinal tract, respiratory tract, peripheral nerves, skin,
and tongue
• Secondary - kidneys, liver, and spleen
• Gross - the organ is enlarged and the tissue typically appears gray with a waxy,
firm consistency
15. On histologic examination, the amyloid deposition is always extracellular
begins between cells,
(often closely adjacent to basement membranes)
As the amyloid accumulates, it encroaches on the cells ---destroy
In the AL form ------ perivascular and vascular localizations are common.
18. CONGO RED
• FLUORESCENT DYE; NOT SPECIFIC FOR AMYLOID
Staining – hydrogen bonding between congo red and B pleated sheet in a highly
oriented linear and parallel manner.
If the spatial configuration is altered-----------> reaction fails
Postive birefringence- parallel arrangement of dye molecules
19. • Interpretations :
AMYLOID – SALMON RED
NUCLEI – BLUE
UNDER POLARIZED LIGHT MICROSCOPE:
AMYLOID : APPLE GREEN
COLLAGEN : YELLOW RED
20. Principle : di azo dye which attaches itself parallel to the fibrils of amyloid and
forms non polar hydrogen bonds- shows green birefringence of congo red stained
amyloid under polarised light.
22. • Lugol’s Iodine - : Iodine 5% and KI 10%
Iodine is not soluble in water, therefore KI
I2 + I- ------------ I3-
This makes a linear triiodide ion complex which is soluble. The triiodide ion slips
into the coil of the starch causing an intense blue-black color
23. Metachromatic dyes
Methyl/ crystal violet Toulidine blue
• The dye reacts with the tissues to produce a color different from that of the
original dye and from the rest of the tissue
• It is attributed to stacking of dye cations at the sites of high density of
anionic groups in the tissue. Stacking shortens the wavelength of
maximum absorption
• Substances that can be stained in this way are called chromotropes.
24. METHYL/ CRYSTAL VIOLET
• Metachromatic stains
negatively charged groups on the tissue + cationic dyes
polymerization
original colour of the dye changes to another colour
Amyloid – purple red on a green background
26. THIOFLAVIN T (fluorescent dye)
• Thioflavin T is a benzothiazole salt
• Dye interacts with the quaternary structure of B pleated sheet rather than with
protein moieties, so binding is not dependent on any amino acid sequence.
Acidic pH increases the selectivity by favouring the fluorochrome fraction
binding to amyloid while depressing non amyloid fluorochrome staining.
• In vivo and in vitro
27. ALCIAN BLUE
• PRINCIPLE : polyvalent basic dye
Forms salt linkages with acid groups of
sulphated and carboxylated acid
mucoploysaccharides
• Amyloid deposits - Shades of green
• Fibrin, muscle, cytoplasm – Yellow
• Collagen, stroma - Red
• Nuclei - Black
28. PAS stain
Periodic acid oxidises the 1:2 glycol groups in the tissue to dialdehydes.
Amyloid – light pink
29. HAEMATOXYLIN & EOSIN STAIN
• HEMALUM (ALUMINIUM IONS & OXIDISED HAEMATOXYLIN) ---- NUCLEI
• COUNTERSTAIN WITH AQUEOUS OR ALCOHOLIC SOLUTION OF EOSIN Y
Amyloid - eosinophilic
31. P COMPONENT
• Makes 10% of amyloid weight
• Found on all amyloid fibrils except alzheimers senile plaques
• Stabilizes fibril amyloid protein and decreases their clearance
• Plays role in some of the special stains
32. KIDNEY
most common and most serious feature of the disease
Grossly – unchanged / may be abnormally large, pale, gray, and firm;
in long-standing cases - may be reduced in size.
Microscopically - the amyloid deposits are found in the
glomeruli interstitial peritubular tissue & in the walls of the
blood vessels.
33. • The glomerulus - focal deposits within the mesangial matrix and diffuse or
nodular thickenings of the basement membranes of the capillary loops.
the deposition encroaches on the capillary lumina - total obliteration of the
vascular tuft
The interstitial peritubular deposits
amorphous pink casts within the tubular
lumens
walls of blood vessels - marked vascular
narrowing.
34. SPLEEN
• moderate or even marked enlargement (200 to 800 gm).
• 2 PATTERNS –
deposits limited to the splenic follicles, producing tapioca-like granules on gross
examination (“sago spleen”)
35. involve the splenic sinuses, eventually extending to the splenic pulp, with
formation of large, sheetlike deposits (“lardaceous spleen”)
In both patterns, the spleen is firm in consistency.
36. LIVER
GROSS - massive enlargement (9000 gm). Pale, grayish, and waxy on both the
external surface and the cut section.
MICRO - amyloid deposits first appear in the space of Disse
adjacent hepatic parenchyma and sinusoids
37. HEART
• systemic involvement - AL form.
• The isolated form (senile amyloidosis) – older persons.
minimal to moderate cardiac enlargement
gray-pink, dewdrop-like subendocardial elevations(atrial chambers)
histologic examination - throughout the myocardium
myocardial fibers
pressure atrophy
38. Clinical Course & Diagnosis
• Nonspecific complaints - weakness, fatigue, and weight loss
• Later - renal disease, hepatomegaly, splenomegaly, or cardiac abnormalities
• Biopsy and subsequent Congo red staining is the most important tool
• renal biopsy - urinary abnormalities
Rectal and gingival biopsy specimens - generalized amyloidosis.
Examination of abdominal fat aspirates stained with Congo red - simple, low-risk
method.
Bone marrow examination - plasmacytosis